These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9491899

  • 1. Structure and binding properties of serum albumin in uremic patients at different periods of hemodialysis.
    Sarnatskaya VV, Ivanov AI, Nikolaev VG, Rotellar E, von Appen K, Haspar M, Maslenny VN, Klinkmann H.
    Artif Organs; 1998 Feb; 22(2):107-15. PubMed ID: 9491899
    [Abstract] [Full Text] [Related]

  • 2. The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst.
    Mera K, Anraku M, Kitamura K, Nakajou K, Maruyama T, Otagiri M.
    Biochem Biophys Res Commun; 2005 Sep 09; 334(4):1322-8. PubMed ID: 16054887
    [Abstract] [Full Text] [Related]

  • 3. Impairments of the biological properties of serum albumin in patients on haemodialysis.
    Lim PS, Cheng YM, Yang SM.
    Nephrology (Carlton); 2007 Feb 09; 12(1):18-24. PubMed ID: 17295656
    [Abstract] [Full Text] [Related]

  • 4. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T, Takamura N, Nishii R, Tokunaga J, Yoshimoto M, Kawai K.
    Nephrol Dial Transplant; 2008 Jul 09; 23(7):2304-10. PubMed ID: 18390890
    [Abstract] [Full Text] [Related]

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 09; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 6. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
    Terawaki H, Nakayama K, Matsuyama Y, Nakayama M, Sato T, Hosoya T, Era S, Ito S.
    Blood Purif; 2007 Nov 09; 25(3):274-9. PubMed ID: 17460395
    [Abstract] [Full Text] [Related]

  • 7. Global fibrinolytic capacity in children on dialysis.
    Agras PI, Baskin E, Cengiz N, Kirazli S, Saatci U, Ozbek N.
    Thromb Res; 2005 Nov 09; 115(3):185-9. PubMed ID: 15617740
    [Abstract] [Full Text] [Related]

  • 8. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
    Sarnatskaya VV, Yushko LA, Sakhno LA, Nikolaev VG, Nikolaev AV, Grinenko DV, Mikhalovsky SV.
    Artif Cells Blood Substit Immobil Biotechnol; 2007 Nov 09; 35(3):287-308. PubMed ID: 17573628
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun 09; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 11. Biophysical characterization of albumin preparations from blood serum of healthy donors and patients with renal diseases. Part I: spectrofluorometric analysis.
    Parkhomenko TV, Klicenko OA, Shavlovski MM, Kuznetsova IM, Uversky VN, Turoverov KK.
    Med Sci Monit; 2002 Jul 09; 8(7):BR261-5. PubMed ID: 12118188
    [Abstract] [Full Text] [Related]

  • 12. [Cardiovascular risk markers in hemodialysis].
    Urso S, Milone F, Garozzo M, Cannavò ME, Biondi A, Battaglia G.
    G Ital Nefrol; 2004 Jul 09; 21 Suppl 30():S212-6. PubMed ID: 15750988
    [Abstract] [Full Text] [Related]

  • 13. Plasma protein carbonylation in chronic uremia.
    Pavone B, Sirolli V, Giardinelli A, Bucci S, Forlì F, Di Cesare M, Sacchetta P, Di Pietro N, Pandolfi A, Urbani A, Bonomini M.
    J Nephrol; 2011 Jul 09; 24(4):453-64. PubMed ID: 21607919
    [Abstract] [Full Text] [Related]

  • 14. Hemodialysis reduces the viral load in uremic patients with chronic hepatitis B infection.
    Tseng GY, Lin HJ, Fang CT, Cheng YT, Huang CH, Tseng GC, Wang PC, Hung TL, Deng YC, Tsai CC, Yang KY.
    Ren Fail; 2008 Jul 09; 30(10):1000-5. PubMed ID: 19016152
    [Abstract] [Full Text] [Related]

  • 15. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW, Netherlands Cooperative Study on the Adequacy of Dialysis-II Study Group.
    J Ren Nutr; 2009 Mar 09; 19(2):127-35. PubMed ID: 19218039
    [Abstract] [Full Text] [Related]

  • 16. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M, Akca R, Sarandol E, Dilek K.
    J Nephrol; 2004 Mar 09; 17(6):813-8. PubMed ID: 15593056
    [Abstract] [Full Text] [Related]

  • 17. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
    Adamowicz A, Trafikowska U, Trafikowska A, Zachara B, Manitius J.
    Med Sci Monit; 2002 Mar 09; 8(3):CR202-5. PubMed ID: 11887037
    [Abstract] [Full Text] [Related]

  • 18. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C.
    Nephrol Ther; 2009 Jul 09; 5(4):306-12. PubMed ID: 19481513
    [Abstract] [Full Text] [Related]

  • 19. Oxidative modifications impair albumin quantification.
    Michelis R, Kristal B, Snitkovsky T, Sela S.
    Biochem Biophys Res Commun; 2010 Oct 08; 401(1):137-42. PubMed ID: 20833127
    [Abstract] [Full Text] [Related]

  • 20. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients.
    Soejima A, Matsuzawa N, Miyake N, Karube M, Fukuoka K, Nakabayashi K, Kitamoto K, Nagasawa T.
    Clin Nephrol; 1999 Feb 08; 51(2):92-7. PubMed ID: 10069644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.